Global Navigation
Office of The Attorney General
The State of New Jersey Office of The Attorney General (Dept. of Law & Public Safety) The State of New Jersey NJ Home Services A to Z Departments/Agencies OAG Frequently Asked Questions
Services A to Z Departments/Agencies OAG Frequently Asked Questions
OAG Home
OAG Contact
spacer
Back to News Releases
OAG Home Attorney General's Biography
Attorney General's Biography
spacer spacer spacer
   
 
spacer spacer spacer
spacer spacer spacer
For Immediate Release: For Further Information:
April 23, 2015

Office of The Attorney General
- John J. Hoffman, Acting Attorney General
Division of Consumer Affairs
- Steve C. Lee, Acting Director
Division of Law
- Jeffrey S. Jacobson, Director
Media Inquiries-
Jeff Lamm or
Neal Buccino
973-504-6327
 

Citizen Inquiries-

609-984-5828
spacer
spacer spacer spacer
spacer
State Board Temporarily Suspends License of Doctor Who Allegedly Prescribed Highly Addictive Pain Killers Indiscriminately
spacer
spacer spacer spacer
spacer
spacer
spacer spacer spacer
spacer
NEWARK – Beginning today, a Passaic County doctor is temporarily barred from seeing or treating patients while he awaits a disciplinary hearing before the State Board of Medical Examiners (BME) for allegedly prescribing highly addictive pain killers to patients without proper medical justification.

Dr. Mohamed Kawam Jabakji (known as Dr. Kawam), who maintains a medical practice in Prospect Park, is temporarily suspended until further action by the BME. The BME acted after the State produced information that Kawam allegedly prescribed pain killers, including Oxycodone, Percocet and Codeine, to at least six patients without performing physical examinations or developing a plan of treatment for each patient. Kawam maintained blank or virtually blank patient records for each of the six patients despite prescribing prodigious quantities of highly addictive narcotics and other controlled substances.

“We’re pleased the Board of Medical Examiners recognized the clear and imminent danger posed by Dr. Kawam and protected the public through this temporary license suspension,” Acting Attorney General John J. Hoffman said. “Indiscriminate prescribing of pain killers is often the first step on the road to heroin addiction, which is why taking immediate action is necessary.”

The BME will consider further disciplinary action against Kawam at a future hearing.

“Patients entrust their well-being to their doctors and the alleged actions of Dr. Kawam violated that trust,” said Steve Lee, Acting Director of the State Division of Consumer Affairs. “Dr. Kawam’s alleged actions demonstrated a deviation from accepted standards of care that placed patients at unnecessary risk.”

In its filed complaint, the State alleged Kawam’s treatment of the six cited patients demonstrated “gross deviation from the standard of care given the lack of examinations, time lapses between visits, failure to address clear drug seeking and doctor shopping behavior and absence of any legitimate medical record keeping.” The State further alleged that Kawam’s actions demonstrated “gross negligence” which endangered these patients.

The Division of Consumer Affairs’ Enforcement Bureau conducted this investigation. Deputy Attorney General David M. Puteska, Assistant Chief of the Professional Boards Prosecution Section in the Division of Law, represented the State. Deputy Attorney General Megan Cordoma provided legal counsel to the Board.

Acting Attorney General Hoffman and Acting Director Lee wish to thank the Drug Enforcement Administration for its assistance in bringing this matter to the State’s attention and in providing invaluable assistance during this investigation.

The Office of the Attorney General and Division of Consumer Affairs have launched a comprehensive strategy to fight the diversion and abuse prescription pain killers. This effort includes:

  • The expansion of the New Jersey Prescription Monitoring Program (NJPMP), to include direct data-sharing with the PMPs maintained by the States of Connecticut and Delaware, and efforts to build a similar data-sharing partnership with New York State. As of April 9, 2015, 88.4% of the state’s 29,400 licensed doctors had registered to use the NJPMP database. About 169,000 user requests were submitted to the NJPMP during the preceding 30-day period. This statewide database tracks the prescription sale of all drugs, including prescription pain killers, classified as Controlled Dangerous Substances (CDS) or Human Growth Hormone into New Jersey.

  • Launching the first-in-the-nation online app that allows authorized users of the NJPMP access to the database via Apple smartphones and handheld devices. The app is located at https://appsto.re/us/oUv23.i.
  • The creation of the Pain Management Council, an advisory body that will help the Division of Consumer Affairs develop best practice recommendations for New Jersey’s healthcare professionals. The goal is to create voluntary guidelines that will enable prescribers to provide pain management, while maintaining effective controls to prevent drug diversion and abuse.
  • The introduction of new New Jersey prescription blanks with enhanced safety features to prevent misuse.

  • Expanding “Project Medicine Drop” to 122 locations across New Jersey. The Division of Consumer Affairs installed secure "prescription drug drop boxes" at police departments, sheriff's offices, and State Police barracks, allowing citizens to safely dispose of their unused, excess, or expired prescription medications at any time without an appointment.
spacer
spacer spacer spacer
spacer
 
News Index Page I top
 
Executive Assistant Attorney General
Attorney General's Message Ask the Attorney General
Contact OAG About OAG
OAG News OAG Frequently Asked Questions
OAG Library Employment
OAG Grants Proposed Rules
OAG History OAG Services A-Z
Statutes
OAG Agencies / Programs / Units
Other News Pages Otras Noticias en Español Division of NJ State Police Division of Law News Governor's Office News Division of Highway Traffic Safety News Office of the Insurance Fraud Prosecutor Juvenile Justice Commission News Division on Civil Rights News Division of Consumer Affairs News Division of Criminal Justice News Election Law Enforcement Commission Division of Gaming Enforcement News
NJ State Police News Governor's Office News Division of Highway Traffic Safety News Office of the Insurance Fraud Prosecutor Juvenile Justice Commission News Division on Civil Rights News Division of Consumer Affairs News Division of Criminal Justice News Election Law Enforcement Commission Division of Elections News Division of Gaming Enforcement News Office of Government Integrity News
   
Contact Us | Privacy Notice | Legal Statement | Accessibility Statement
NJ Home Logo
Departmental: OAG Home | Contact OAG | About OAG | OAG News | OAG FAQs
Statewide: NJ Home | Services A to Z | Departments/Agencies | FAQs
Copyright © State of New Jersey
This page is maintained by OAG Communications. Comments/Questions: email or call 609-292-4925
OAG Home OAG Home NJ State Police News Governor's Office News Division of Highway Traffic Safety News Office of the Insurance Fraud Prosecutor Juvenile Justice Commission News Division on Civil Rights News Division of Consumer Affairs News Division of Criminal Justice News Election Law Enforcement Commission Division of Elections News Division of Gaming Enforcement News Office of Government Integrity News Click to Enlarge Image Click to Enlarge Image Click to Enlarge Graphic Click to enlarge chart Click to enlarge map Click to Enlarge Click to Enlarge Click to Enlarge Click to Enlarge Click to Enlarge Click to Enlarge Click to Enlarge Click to Enlarge Click to Enlarge Click to Enlarge Click to Enlarge Click to Enlarge Click to Enlarge Click to Enlarge Click to Enlarge Click to Enlarge Click to Enlarge Click to Enlarge Click to Enlarge Click to Enlarge Click to Enlarge Click to Enlarge Click on image to enlarge... Click on image to enlarge... Click to enlarge...Click to enlarge...Click to enlarge...Click to enlarge... Click to enlarge...